Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr-Jun;7(2):68-74.
doi: 10.4103/2229-3485.179431.

MicroRNA therapeutics: Discovering novel targets and developing specific therapy

Ajay Francis Christopher  1 , Raman Preet Kaur  1 , Gunpreet Kaur  1 , Amandeep Kaur  1 , Vikas Gupta  1 , Parveen Bansal  1
Affiliations
Review

MicroRNA therapeutics: Discovering novel targets and developing specific therapy

Ajay Francis Christopher et al. Perspect Clin Res. 2016 Apr-Jun.

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression in diverse biological process. They act as intracellular mediators that are necessary for various biological processes. MicroRNAs targeting pathways of human disease provide a new and potential powerful candidate for therapeutic intervention against various pathological conditions. Even though, the information about miRNA biology has significantly enriched but we still do not completely understand the mechanism of miRNA gene regulation. Various groups across the globe and pharmaceutical companies are conducting research and developments to explore miRNA based therapy and build a whole new area of miroRNA therapeutics. Consequently, few miRNAs have entered the preclinical and clinical stage and soon might be available in the market for use in humans.

Keywords: Clinical stage; gene expression; microRNA; therapeutics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic overview of microRNA biogenesis
Figure 2
Figure 2
Process of microRNA discovery and development
See this image and copyright information in PMC

References

    1. Bader AG, Brown D, Winkler M. The promise of microRNA replacement therapy. Cancer Res. 2010;70:7027–30. - PMC - PubMed
    1. Czech MP. MicroRNAs as therapeutic targets. N Engl J Med. 2006;354:1194–5. - PubMed
    1. Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54. - PubMed
    1. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901–6. - PubMed
    1. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8. - PubMed